Literature DB >> 9031

Human skin proteases. Fractionation of psoriasis scale proteases and separation of a plasminogen activator and a histone hydrolysing protease.

J E Fräki, V K Hopsu-Havu.   

Abstract

Psoriatic scale proteases were found to be extracted effectively in salt solution (1 mol/l) containing Triton X-100 (5 g/l). The extraction in dilute buffer or sucrose yielded low activities. The acid (0.25 N H2SO4) and KSCN (2 mol/l) solutions effectively extracted plasminogen activator. Fibrinolysin was most active in salt (1 mol/l KCl) and in KSCN (2 mol/l) extracts. Psoriatic scale proteases were fractionated by Sephadex G-100 gel filtration and further by DEAE cellulose chromatography. Five different enzyme preparations were obtained. The first preparation, resembling cathepsin D, effectively hydrolysed hemoglobin at pH 3.5 and casein at pH 5.8 and was insensitive to protease modifiers. The second preparation effectively hydrolysed trypsin substrates (AGLME, TAME, BAEE and BANA) and also histone and casein at pH 7.2 and was inhibited by protease inhibitors, TLCK and E-600. The third preparation hydrolysed histone and casein at pH 10.2 and was effectively inhibited by E-600 and partially by protease inhibitors and TPCK. The fourth preparation, resembling cathepsin B1, hydrolysed BANA and BAEE at pH 5.8 and was activated by SH-reagents and EDTA. The fifth enzyme preparation hydrolysed ATEE and was inhibited by E-600 and TPCK. Plasminogen activator was found mainly in the second enzyme preparation and fibrinolysin activity in the third and fifth enzyme preparations. The second, third and fifth enzyme preparations were different from the enzymes found in healthy human skin. The proteases of psoriatic scale resemble those of tissue and cell cultures undergoing rapid cell division. The possible role of proteases in the increased cell division in psoriasis plaque is discussed.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 9031     DOI: 10.1007/BF00567358

Source DB:  PubMed          Journal:  Arch Dermatol Res            Impact factor:   3.017


  36 in total

1.  [Studies on peptidases in the normal and diseased skin of psoriasis patients].

Authors:  W KELLER; J M PASCHOUD; B SCHMIDLI
Journal:  Arch Klin Exp Dermatol       Date:  1956

2.  Human skin proteases. Separation and characterization of two acid proteases resembling cathepsin B1 and cathepsin D and of an inhibitor of cathepsin B1.

Authors:  J E Fräki
Journal:  Arch Dermatol Res       Date:  1976-06-21       Impact factor: 3.017

3.  Purification and characterization of a cellular fibrinolytic factor associated with oncogenic transformation: the plasminogen activator from SV-40-transformed hamster cells.

Authors:  J K Christman; G Acs
Journal:  Biochim Biophys Acta       Date:  1974-03-27

4.  [Proteolytic activity of psoriacic scales].

Authors:  G Schwartze; H Hanson
Journal:  Dermatol Monatsschr       Date:  1971-05

5.  Inhibitors and proactivators of fibrinolysis in human epidermis.

Authors:  K Nishioka; T J Ryan
Journal:  Br J Dermatol       Date:  1971-12       Impact factor: 9.302

6.  [Quantitative determination of the fibrinolytic tissue activator in normal and pathological skin].

Authors:  U F Haustein
Journal:  Arch Klin Exp Dermatol       Date:  1968

7.  Thromboplastin and plasminogen activator in tissues of the rabbit.

Authors:  P Glas; T Astrup
Journal:  Am J Physiol       Date:  1970-10

8.  [Contribution to the study of bovine chymotrypsinogen B].

Authors:  O Guy; D Gratecos; M Rovery; P Desnuelle
Journal:  Biochim Biophys Acta       Date:  1966-02-28

9.  Further studies of a thymus nucleohistone-associated protease.

Authors:  J Bartley; R Chalkley
Journal:  J Biol Chem       Date:  1970-09-10       Impact factor: 5.157

10.  [Physiology and physiopathology of general and local fibrinolysis in healthy persons and patients with skin diseases].

Authors:  U F Haustein
Journal:  Dermatol Monatsschr       Date:  1971-07
View more
  6 in total

1.  Alpha 1-proteinase inhibitor in psoriasis: reduced activity in symptom-free patients and during flare.

Authors:  D Barszcz; Z Zarebska; M Glińska-Ferenz; S Jabłońska; M Tigałonowa; W Gliński
Journal:  Arch Dermatol Res       Date:  1988       Impact factor: 3.017

2.  Cysteine proteinase inhibitors in psoriatic epidermis.

Authors:  V K Hopsu-Havu; I A Joronen; M Järvinen; A Rinne
Journal:  Arch Dermatol Res       Date:  1983       Impact factor: 3.017

3.  Plasminogen activators of psoriatic scale extracts. Separation of two plasminogen activators by isoelectric focusing.

Authors:  J E Fräki; B M Djupsund; V K Hopsu-Havu
Journal:  Arch Dermatol Res       Date:  1978-05-31       Impact factor: 3.017

4.  Enzyme- and immunohistochemical localization of mast cell tryptase in psoriatic skin.

Authors:  I T Harvima; A Naukkarinen; R J Harvima; M Horsmanheimo
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

5.  Proteomics reveals that quinoa bioester promotes replenishing effects in epidermal tissue.

Authors:  Amanda C Camillo-Andrade; Marlon D M Santos; Juliana S G Fischer; Bruna B Swinka; Bruna Bosquetti; Desirée C Schuck; Marcia R Pincerati; Marcio Lorencini; Paulo C Carvalho
Journal:  Sci Rep       Date:  2020-11-10       Impact factor: 4.379

Review 6.  A Review on the Role of Ethylenediaminetetraacetic Acid (EDTA) in the Treatment and Understanding of Psoriasis.

Authors:  Amreen Sunil; Gurneet Shaheed; Akshay J Reddy; Neel Nawathey; Hetal Brahmbhatt
Journal:  Cureus       Date:  2021-07-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.